1. Jo, K. S., Rosner, M. H., Okusa M. D. Pharmacologic Treatment of Acute Kidney Injury: Why Drugs Haven’t Worked and What Is on the Horizon. Clin. J. Am. Soc. Nephrol., 2007, 2, p. 356–365.
2. Mishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K. et al. Identification of Neutrophil Gelatinase-Associated Lipocalin as a Novel Early Urinary Biomarker for Ischemic Renal Injury. J. Am. Soc. Nephrol., 2003, 14, p. 2534–2543.
3. Nquyen, M. T., Devarajan, P. Biomarkers for the early detection of acute kidney injury. Pediatr. Nephrol., 2008, 23, p. 2151–2157.
4. Grenier, F., Ali, S., Syed, H. et al. Multi-site Evaluation of an Assay in Development for Urine NGAL on the Abbott ARCHITECT Analyzer. American Association of Clinical Chemists Annual Meeting, Washington, DC, July 27–31, 2008 (abstract).
5. Mishra, J., Dent, C., Tarabishi, R. et al. Neutrophil gelatinase-associated lipocalin as a biomarker for acute renal injury after cardiac surgery. The Lancet, 2005, 365, 9466, p. 1231–1238.
6. Dent, C. L., Ma, Q., Dastrala, S. et al. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit. Care, 2007. Dostupný na www: http://ccforum.com/content/11/6/R127.
7. Wagener, G., Jan, M., Kim, M. et al. Association between Increases in Urinary Neutrophil Gelatinase-associated Lipocalin and Acute Renal Dysfunction after Adult Cardiac Surgery. Anestesiology, 2006, 105, p. 485–491.
8. Tuladhar, S. M., Puntmann, V. O., Soni, M. et al. Rapid Detection of Acute Kidney Injury by Plasma and Urinary Neutrophil Gelatinase-associated Lipocalin after Cardiopulmonary Bypass. J. Cardiovasc. Pharmacol., 2009, 53, 3, p. 261–266.
9. Wagener, G., Gubitosa, G., Wang, S. et al. Urinary Neutrophil Gelatinase-Associated Lipocalin and Acute Kidney Injury After Cardiac Surgery. Am. J. Kidney Diseases, 2008, 52, 3, p. 425–433.
10. Mishra, J., Ma, Q., Kelly, C. et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr. Nephrol., 2006, 21, p. 856–863.
11. Bachorzewska-Gajewska, H., Malyszko, J., Sitniewska, E. et al. Neutrophil gelatinaseassociated lipocalin and renal function after percutaneous coronary interventions. Am. J. Nephrol., 2006, 6, p. 1639–1645.
12. Cruz, D. N., Cal, M., Garzotto, F. et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med., 2010, 36, p. 444–451.
13. Bagshaw, S. M., Bennett, M., Haase, M. et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med., 2010, 36, p. 452–461.
14. Haase, M., Bellomo, R., Devarajan, P. et al. Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Prognosis in Acute Kidney Injury: A Systematic Review and Meta-analysis. Am. J. Kidney Diseases, 2009, 54, 6, p. 1012–1024.
15. Mori, K., Lee, H. T., Rapoport, D. et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J. Clin. Investig., 2005, 115, 3, p. 610–621.
16. Bagshaw, S. M., Gibney, R. T. N. Conventional markers of kidney function. Crit. Care Med., 2008, 36, 4 suppl., p. 152–158.
17. Bokenhamp, A., Laarman, C., Braam, K. I. et al. Effect of Corticosteroid Therapy on Low-Molecular-Weight Protein Markers of Kidney Function. Clin. Chemistry, 2007, 53, p. 2219–2221.
18. Hollander, J. G., Wulkan, R. W. et al. Is Cystatin C a Marker of Glomerular Filtration Rate in Thyroid Dysfunction? Clin. Chemistry, 2003, 49, p. 1558–1559.
19. Vaidya, V. S., Waikar, S. S., Ferguson, M. A. et al. Urinary Biomarkers for Sensitive and Specific Detection of Acute Kidney Injury in Humans. Clin. Transl. Sci., 2008, 1, 3, p. 200–208.
20. Reese, P. P., Feldman, H. I. More Evidence that Cystatin C Predicts Mortality Better than Creatinine. J. Am. Soc. Nephrol., 2009, 20, p. 2088–2090.
21. VandeVoorde, R. G., Katman, T. I., Ma, Q. et al. Serum NGAL and Cystatin C as predictive biomarkers for acute kidney injury. J. Am. Soc. Nephrol., 2006, 17, 404 abstr.
22. Soto, K., Coelho, S., Rodriques, B. et al. Cystatin C as a Marker of Acute Kidney Injury in the Emergency Department. Clin. J. Am. Soc. Nephrol., 2010, epub ahead of print.
23. Bagshaw, S. M., Bellomo, R. Early diagnosis of acute kidney injury. Cur. Opin. Crit. Care, 2007, 13, p. 638–644.
24. Parikh, C. R., Abraham, E., Ancukiewicz. M., Edelstein. C. L. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J. Am. Soc. Nephrol., 2005, 16, p. 3046–3052.
25. Liangos, O., Perianayagam, M. C., Vaidya, V. S. et al. Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J. Am. Soc. Nephrol., 2007, 18, p. 904–912.
26. Ferguson, M. A., Vaidya, V. S., Bonventre, J. V. Biomarkers of nephrotoxic acute kidney injury. Toxicology, 2008, 245, p. 182–193.
27. Han, W. K., Bonventre, J. V. Biologic markers for the early detection of acute kidney injury. Curr. Opin. Crit. Care, 2004, 10, p. 476–482.
28. Negishi, K., Noiri, E., Doi, K. et al. Monitoring of Urinary L-Type Fatty Acid-Binding Protein Predicts Histological Severity of Acute Kidney Injury. Am. J. Pathol., 2009, 174, 4, p. 1154–1159.
29. Ferguson, M. A., Vaidya, V. S., Waikar, S. S. et al. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int., 2009. Dostupný na www: http://www.nature.com/ki/index.html (10.1038/ki.2009.422).
30. Portilla, D., Dent. C., Sugaya. T. et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int., 2008, 73, 4, p. 465–472.
31. Zhou, H., Pisitkun, T., Aponte, A. et al. Exosomal Fetuin-A identified by proteomics: a novel urinary biomarler for detecting acute kidney injury. Kidney Int., 2006, 70, 10, p. 1847–1857.